Recombinant p27 Antibody / p27Kip1
P27Kip1 functions as a negative regulator of G1 progression and has been proposed to function as a possible mediator of TGF-b induced G1 arrest. p27Kip1 is a candidate tumor suppressor gene. Reportedly, low p27 expression has been associated with unfavorable prognosis in renal cell carcinoma, colon carcinoma, breast carcinomas, non-small-cell lung carcinoma, hepatocellular carcinoma, multiple myeloma, and lymph node metastases in papillary carcinoma of the thyroid, as well as a more aggressive phenotype in carcinoma of the cervix.
Product Specifications
CAS Number
9000-83-3
Specifications
Immunohistochemistry (FFPE) : 1-2 µg/mL
UniProt
P46527
Host
Rabbit
Reactivity
Human
Immunogen
Recombinant full-length human CDKN1B/p27Kip1 protein was used as the immunogen for the recombinant p27 antibody.
Clonality
Recombinant Monoclonal
Isotype
IgG κ
Clone
KIP1/9168R
Type
Recombinant
Applications
IHC-P
Purity
Protein A/G affinity
Format
Purified
Buffer
0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Reconstitution
Aliquot the recombinant p27 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Limitations
This recombinant p27 antibody is available for research use only.
Storage Conditions
Aliquot the recombinant p27 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
Formulation
0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05% sodium azide
Applications Notes
Optimal dilution of the recombinant p27 antibody should be determined by the researcher.
Location
Nucleus
Image Legend
Documents
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog